These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 29486737
1. High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada. Wilton J, Noor SW, Schnubb A, Lawless J, Hart TA, Grennan T, Fowler S, Maxwell J, Tan DHS. BMC Public Health; 2018 Feb 27; 18(1):292. PubMed ID: 29486737 [Abstract] [Full Text] [Related]
2. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, Tan DH. J Int AIDS Soc; 2016 Feb 27; 19(1):20777. PubMed ID: 27265490 [Abstract] [Full Text] [Related]
3. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG, PrEP Brasil Study Team. Lancet HIV; 2018 Mar 27; 5(3):e136-e145. PubMed ID: 29467098 [Abstract] [Full Text] [Related]
4. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis. Hugo JM, Stall RD, Rebe K, Egan JE, De Swardt G, Struthers H, McIntyre JA. AIDS Behav; 2016 Dec 27; 20(Suppl 3):357-364. PubMed ID: 27631366 [Abstract] [Full Text] [Related]
5. Perceived HIV risk, actual sexual HIV risk and willingness to take pre-exposure prophylaxis among men who have sex with men in Toronto, Canada. Kesler MA, Kaul R, Myers T, Liu J, Loutfy M, Remis RS, Gesink D. AIDS Care; 2016 Nov 27; 28(11):1378-85. PubMed ID: 27136725 [Abstract] [Full Text] [Related]
6. Moderating Effect of Pre-Exposure Prophylaxis Use on the Association Between Sexual Risk Behavior and Perceived Risk of HIV Among Brazilian Gay, Bisexual, and Other Men Who Have Sex With Men: Cross-Sectional Study. Blair KJ, Torres TS, Hoagland B, Bezerra DRB, Veloso VG, Grinsztejn B, Clark J, Luz PM. JMIR Public Health Surveill; 2023 Oct 05; 9():e45134. PubMed ID: 37796573 [Abstract] [Full Text] [Related]
7. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, ANRS IPERGAY Study Group. Lancet HIV; 2017 Sep 05; 4(9):e402-e410. PubMed ID: 28747274 [Abstract] [Full Text] [Related]
9. Alcohol consumption, substance use, and depression in relation to HIV Pre-Exposure Prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men. Shuper PA, Joharchi N, Bogoch II, Loutfy M, Crouzat F, El-Helou P, Knox DC, Woodward K, Rehm J. BMC Public Health; 2020 Nov 25; 20(1):1782. PubMed ID: 33256651 [Abstract] [Full Text] [Related]
10. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas Castro D, Chidiac C, Chas J, Meyer L, Molina JM, Spire B, ANRS IPERGAY Study Group. AIDS Care; 2016 Nov 25; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400 [Abstract] [Full Text] [Related]
11. Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men. Ross EL, Cinti SK, Hutton DW. J Acquir Immune Defic Syndr; 2016 Jul 01; 72(3):e61-7. PubMed ID: 26977749 [Abstract] [Full Text] [Related]
12. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Hanum N, Cambiano V, Sewell J, Phillips AN, Rodger AJ, Speakman A, Nwokolo N, Asboe D, Gilson R, Clarke A, Miltz AR, Collins S, Lampe FC, AURAH2 Study Group. Lancet Public Health; 2020 Sep 01; 5(9):e501-e511. PubMed ID: 32888443 [Abstract] [Full Text] [Related]
13. Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year. Wang Z, Mo PKH, Ip M, Fang Y, Lau JTF. BMC Infect Dis; 2020 Apr 22; 20(1):299. PubMed ID: 32321442 [Abstract] [Full Text] [Related]
15. Using Online Settings to Identify Gay and Bisexual Men Willing to Take or With Experience Taking PrEP: Implications for Researchers and Providers. Grov C, Rendina HJ, Jimenez R, Parsons JT. AIDS Educ Prev; 2016 Oct 22; 28(5):378-392. PubMed ID: 27710085 [Abstract] [Full Text] [Related]
16. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol. Sharma M, Chris A, Chan A, Knox DC, Wilton J, McEwen O, Mishra S, Grace D, Rogers T, Bayoumi AM, Maxwell J, Shahin R, Bogoch I, Gilbert M, Tan DHS. BMC Health Serv Res; 2018 Jul 03; 18(1):513. PubMed ID: 29970087 [Abstract] [Full Text] [Related]
17. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial. Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, McNulty A, Smith D, Jin F, Amin J, Cooper DA, Grulich AE, EPIC-NSW study group. BMC Public Health; 2018 Feb 02; 18(1):210. PubMed ID: 29394918 [Abstract] [Full Text] [Related]
18. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, Matheson T, Trainor N, Blue RW, Estrada Y, Coleman ME, Elion R, Castro JG, Chege W, Philip SS, Buchbinder S, Kolber MA, Liu AY. J Acquir Immune Defic Syndr; 2015 Apr 01; 68(4):439-48. PubMed ID: 25501614 [Abstract] [Full Text] [Related]
19. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, Schmidt HA, Zablotska I, Price K, Whittaker B, Chant K, Cooper C, McGill S, Telfer B, Yeung B, Levitt G, Ogilvie EE, Dharan NJ, Hammoud MA, Vaccher S, Watchirs-Smith L, McNulty A, Smith DJ, Allen DM, Baker D, Bloch M, Bopage RI, Brown K, Carr A, Carmody CJ, Collins KL, Finlayson R, Foster R, Jackson EY, Lewis DA, Lusk J, O'Connor CC, Ryder N, Vlahakis E, Read P, Cooper DA, Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group. Lancet HIV; 2018 Nov 01; 5(11):e629-e637. PubMed ID: 30343026 [Abstract] [Full Text] [Related]